Key result
Treatment with steroids and antiaggregants in patients with lupus anticoagulant and prior fetal death resulted in 13 live births out of 27 pregnancies.
Why the study?
Does treatment with prednisone and antiaggregants improve live birth rates in pregnant patients with lupus anticoagulant?
Observational (n=19)
Does treatment with prednisone and antiaggregants improve live birth rates in pregnant patients with lupus anticoagulant?
Treatment with steroids and antiaggregants may be beneficial for second and third-trimester fetal death and clinical SLE, but its role in primary habitual abortion or patients without previous fetal loss is questionable.
Answers are grounded in this paper and cite their sources.
May support steroids plus antiaggregants after prior fetal loss; hypothesis-generating and should not change practice without RCTs.
There are many reports in the literature associating lupus anticoagulant with fetal death. Successful pregnancies have been reported following suppression of the antibody by prednisone and the addition of antiaggregants and possibly anticoagulants. This report describes our experience treating such patients and the outcome of subsequent pregnancies. The results are less successful than the figures in the literature, 13 live births out of 27 pregnancies in 19 patients. This may be due to lupus anticoagulant being diagnosed as the cause for a wide variety of clinical presentations including habitual first trimester abortion, mid trimester fetal death, intrauterine growth retardation and placental dysfunction in the third trimester. Our experience shows that steroids and antiaggregants have a definite place in cases of second and third trimester fetal death and in cases of clinical systemic lupus erythematosus. However, lupus anticoagulant is one of a spectrum of autoantibodies whose pathophysiology has not been fully elucidated. It is questionable whether this regimen of treatment has a place in patients with no previous fetal loss or in cases of primary habitual abortion.
No takes yet. Share an insight, caveat, or question.
Carp et al. (2010) conducted an observational in Fetal demise associated with lupus anticoagulant (n=19). Prednisone and antiaggregants was evaluated on Live births. Treatment with steroids and antiaggregants in patients with lupus anticoagulant and prior fetal death resulted in 13 live births out of 27 pregnancies.
Synapse has enriched 10 related papers. Consider them for comparative context: